NMRA vs NVST · $283.5M cap vs P/E 56, rev $2.51B
Neumora Therapeutics, Inc. (NMRA) versus Envista Holdings Corp (NVST) — a side-by-side from cached financials, not a winner call.
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
Envista Holdings Corp (NVST) is a medical instruments & supplies company listed on US.
NMRA does not have a complete income-statement cache yet.
Latest reported NVST revenue for 2024-12-31 was $2.51B. Net income was -$1.12B. Revenue was down 2.2% from 2023-12-31 to 2024-12-31. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
NMRA currently screens at market cap $283.5M. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
Not investment advice. Open the NMRA and NVST stock pages for the full models.
Not investment advice.